Dr. Luis Felipe Serrano, MD

Dr. Serrano practices at HCA Florida Osceola Hospital in Kissimmee, Florida, part of HCA Healthcare.

Dr. Serrano's NPI, 1407275324, was assigned on April 8, 2014. Dr. Serrano graduated from Other in 2012. Dr. Serrano holds Florida license ME139335.

Dr. Serrano's primary practice is HCA Florida Osceola Hospital, at 700 West Oak Street, Kissimmee, FL 34741 in Osceola County. The practice phone is (407) 846-2266.

Dr. Serrano's primary practice is HCA Florida Osceola Hospital in Kissimmee, Florida, part of HCA Healthcare. The medical group on file is HCA Florida Osceola Surgical Associates. Dmand AI also links Dr. Serrano to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serrano practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Serrano's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Serrano is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Serrano's licenses on file in 3 states: Florida, Texas and California.

Dmand AI lists colon removal, esophagus, stomach, or upper small intestine surgery and gallbladder removal among the conditions Dr. Serrano treats.

CMS data shows 65 Medicare services from Dr. Serrano across 3 procedure codes in 2024, for 47 Medicare patients. Medicare paid $7,849 for them.

CMS counts 47 Medicare patients who saw Dr. Serrano in 2024. The largest group is 75 to 84, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Serrano's median patient age at 51, with 66% women.

In 2024, Dr. Serrano wrote 129 Medicare Part D claims for 64 patients. 98% of them were for generic drugs. CMS names the drug for 97 of them, across 4 drugs with 11 or more claims each, at $979 in total drug cost. In 2023, CMS named 52 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Serrano for performance year 2024, reported as part of a group. Dr. Serrano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Serrano, published from 2020 to 2025. 2024 was the busiest year, with 2. Dr. Serrano has published most often in J Surg Case Rep. Dr. Serrano's most frequent co-authors are Victor F. Cabrera-Bou, John William Jacobs, MD and Philip Demetrios Kondylis, MD.

CMS Open Payments shows 36 general payments to Dr. Serrano from 19 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Integra LifeSciences Corporation paid the most, $385.

Dr. Serrano graduated from Other in 2012.

Dr. Serrano is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.